05.16.23 -- Developing Robust Supply Chain Strategies

Throughout the pandemic, painkiller and sedative demands spiked, and demand for bupivacaine HCl, a powerful analgesic and anesthetic medicine, dramatically increased. As global authorities work to fill gaps, drug manufacturers and CDMOs have become critical in efforts to stabilize the supply of bupivacaine HCl and other essential drugs.

A pharma company sought a CMO partner with commercial manufacturing capabilities and expertise, cGMP assets, and exemplary quality systems and U.S. FDA track records. Learn how a partner with the right scale-up and commercial production expertise was able to find a cost-effective process to produce the API for a new drug.

The COVID-19 pandemic demanded significant pivots, and technology became critical for continued regulatory operations, including carrying out virtual inspections to assess drug safety and adherence to GMPs. Key decision makers in pharma and biotech companies were surveyed to assess their views on undertaking regulatory processes virtually.

Companies looking to increase cost efficiencies have various considerations to incorporate. Decision-making around effective project management, partnerships strategy, and developing sustainable processes requires crucial consideration throughout drug development. Learn how outsourcing helps to achieve success in these areas, which combine to increase cost efficiency.